Back to Top Skip to main content

Increases to TRICARE pharmacy copayments coming

TRICARE urges you to take command of your health care to enhance your TRICARE experience. TRICARE is changing. Are you ready?

Recommended Content:

TRICARE Pharmacy Program | TRICARE Formulary

On Feb 1, 2018, copayments for prescription drugs at TRICARE Pharmacy Home Delivery and retail pharmacies will increase. These changes are required by law and affect TRICARE beneficiaries who are not active duty service members.

While retail pharmacy and home delivery copayments will increase, prescriptions filled at military pharmacies remain available at no cost. You can save the most money by filling your prescriptions at military pharmacies.

“Military pharmacies and TRICARE Pharmacy Home Delivery will remain the lowest cost pharmacy option for TRICARE beneficiaries,” said U.S. Air Force Lt. Col. Ann McManis, Pharmacy Operations Division at the Defense Health Agency.

Using home delivery, the copayments for a 90-day supply of generic formulary drugs will increase from $0 to $7. For brand-name formulary drugs, copayments will increase from $20 to $24, and copayments for non-formulary drugs. without a medical necessity will increase from $49 to $53.

At a retail network pharmacy, copayments for a 30-day supply of generic formulary drugs will increase from $10 to $11 and from $24 to $28 for brand-name formulary drugs.

In some cases, survivors of active duty service members may be eligible for lower cost-sharing amounts.

TRICARE groups pharmacy drugs into three categories: generic formulary, brand name formulary and non-formulary. You pay the least for generic formulary drugs and the most for non-formulary drugs, regardless of whether you get them from home delivery or a retail pharmacy.

To see the new TRICARE pharmacy copayments, visit To learn more about the TRICARE Pharmacy Program, or move your prescriptions to home delivery, visit  

You also may be interested in...

Request for DoD P&T Committee Consideration of Potential Changes to the Uniform Formulary, Basic Core Formulary or Extended Core Formulary


Please attach MTF P&T Committee comments & meeting minutes, an explanation of the rationale for the request, copies of supporting clinical evidence, and anything else that needs to be considered by the DoD P&T Committee.

Recommended Content:

TRICARE Formulary

DHA PI 6025.08: Pharmacy Enterprise Activity EA


This Defense Health Agency-Procedural Instruction (DHA-PI): a. Based on the authority of References (a) through (c), and in accordance with the guidance of References (d) through (g), establishes the Defense Health Agency’s (DHA) procedures to: (1) Exercise management responsibilities for Pharmacy Shared Service/EA functions in the Military Health System (MHS). This DHA-PI is binding on the MHS and supports the Director’s, DHA, responsibility to develop appropriate management models to maximize efficiencies in the activities carried out by DHA. (2) Recognize the Pharmacy Work Group (PWG) as the operational body to implement pharmacy strategies and programs per the Director’s, DHA, guidance. Also, develop strategic initiatives and business process models to optimize pharmacy operations and programs in accordance with Reference (e). (3) Promulgate guidance, define roles, assign responsibilities, and prescribe procedures for the development, coordination, execution, and implementation of standardized Pharmacy Operations and EA procedures within the MHS and Military Departments (MILDEPs). (4) Execute Pharmacy EA assigned responsibilities and functions, and in accordance with Reference (b), when needed, rely on advice and assistance of governance councils established by the Under Secretary of Defense for Personnel and Readiness and the Assistant Secretary of Defense for Health Affairs (ASD(HA)), including senior representatives of the MILDEPs. (5) Provide DHA combat support agency pharmacy functions, in accordance with Reference (b), specifically involving support for operating forces engaged in planning for, or conducting, military operations, including support during conflict or in the conduct of other military activities related to countering threats to U.S. National Security. The Pharmacy EA innovatively manages and standardizes DoD pharmacy operations in a fiscally responsible manner to optimize readiness, improve health, and lower costs through better care. (6) Support baseline knowledge, skills, and abilities for each wartime pharmacy specialty, addressing gaps between peacetime and deployed operational requirements, in collaboration with the MILDEPs, and military Medical Treatment Facility (MTF) pharmacies. (7) Support programs for skills and knowledge assessments and provide for training/retraining opportunities, as needed, for each wartime pharmacy specialty for military MTF pharmacies. (8) Empower enterprise-level pharmacy clinical communities to define, prioritize, and implement “best-in-class” High Reliability Organization practices to enable readiness through decreasing variation, improving outcomes, and positively impacting healthcare in the MHS. (9) Support the scaling and reconfiguring of pharmacy capabilities required to support the forward operating environment; e.g., hospital ship, combat support hospitals, Expeditionary Medical Support. The Services’ Surgeons General will have deployed medical mission command over health services support of pharmacy resources and capabilities at various levels of command and at diverse locations. b. Transforms varied Tri-Service Pharmacy Operations approaches into a single, integrated DHA Pharmacy Program that standardizes pharmacy shared services and optimizes business processes as directed by the National Defense Authorization Act for Fiscal Year 2017, Section 702 (Reference (c)). c. Drives standardization of institutional and operational commands, sustains and improves medical readiness, creates value within the MHS, and achieves interoperability across platforms to deliver better health care to the warfighter, MHS beneficiaries, and build a medically ready force.

DHA PI 6025.07: Naloxone in the MTFs


This Defense Health Agency-Procedural Instruction (DHA-PI), based on the authority of References (a) through (c), and in accordance with the guidance of References (d) through (h), establishes the Defense Health Agency’s (DHA) procedures for prescribing and dispensing naloxone by pharmacists in MTFs to eligible beneficiaries, upon beneficiary request, or when the pharmacist determines the beneficiary meets the established criteria for being at risk for a life-threatening opiate overdose.

Drugmaker discontinuing Type 2 diabetes medication

Approximately 6,200 Military Health System beneficiaries who are using Tanzeum to aid with managing their Type 2 diabetes will need to switch to an alternative in the wake of GlaxoSmithKline PLC’s announcement that it will stop manufacturing the drug starting in late July. Beneficiaries are advised to speak with their provider about the preferred alternative medications and which is best for them. (MHS graphic)

Providers will guide patients on alternatives

Recommended Content:

TRICARE Formulary

DHA PI 6025.04: Pain Management and Opioid Safety in the MHS


The purpose of our MHS Pain Management Campaign is to enable Clinical Communities to provide evidence-based pain management guided by clinical practice guidelines (CPGs): effectively treat acute and chronic pain; promote non-pharmacologic treatment; prevent acute pain from becoming chronic; and minimize use of opioids with appropriate prescribing only when indicated. The Pain Management Clinical Support Service achieves these ends through clinical improvements in pain care, clinician and patient education, and research. This Defense Health Agency-Procedural Instruction (DHA-PI) is a dual effort between the Pain Management Clinical Support Service and the Clinical Communities to achieve our stated purpose through implementation of the MHS Stepped Care Model.

DHA PI 6025.25: Military Health System (MHS) Drug Take Back (DTB) Program


This Defense Health Agency-Procedural Instruction (DHA-PI), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (g): - Describes procedures for MHS organizations to offer beneficiaries the option of returning their controlled and non-controlled prescriptions and over-the-counter medications for disposal through a DTB program. The DTB program will provide an environmentally safe method for beneficiaries to properly and safely remove unused and expired medications from circulation, including medications that can be used for suicide or suicide attempts and have the potential for misuse, diversion, or accidental poisoning. - Details the tasks and procedures necessary to ensure successful implementation of the MHS DTB program within military Medical Treatment Facilities (MTFs).

Increases to TRICARE pharmacy copayments coming Feb. 1, 2018

TRICARE urges you to take command of your health care to enhance your TRICARE experience.

On Feb. 1, 2018, copayments for prescription drugs at TRICARE Pharmacy Home Delivery and retail pharmacies will increase.

Recommended Content:

TRICARE Pharmacy Program | TRICARE Health Program

WBAMC pharmacist catches serious drug interaction

Dr. Anna Jewula, pharmacist, Department of Pharmacy, William Beaumont Army Medical Center, is recognized for her attentiveness in assisting a patient with a prescription order that contraindicated a previous prescription medication, avoiding a potentially serious drug interaction detrimental to the patient’s health (U.S. Army photo Marcy Sanchez)

Thanks to a pharmacist’s careful eye, one patient avoided a potentially deadly drug interaction

Recommended Content:

Military Hospitals and Clinics | TRICARE Pharmacy Program

Joint Uniform Formulary for Transition of Care


S. 1356, NDAA Conference Report for FY 2016, Joint Explanatory Statement, Sec. 715

Recommended Content:

TRICARE Formulary

Compound Drug Screening

Compound Drug Screening

Watch this episode of TRICARE TV to learn about TRICARE's new compound drug screening procedure.

Recommended Content:

TRICARE Pharmacy Program | Compound Drugs

Military Health System Prescription Transfer Procedures


Effective immediately, all Department of Defense (DoD) military treatment facility (MTF) outpatient pharmacies will accept patient requests for prescription transfers from another MTF and from retail pharmacies. When another pharmacy requests prescription transfer information on behalf of a patient, DoD MTF outpatient pharmacies will respond to the inquirer in a timely manner.

TRICARE Pharmacy Benefit Program Formulary Management Clarification


Questions have arisen concerning the requirement for military treatment facilities (MTFs) to provide medications prescribed by MTF providers. This requirement has commonly been referred to as the "You write it, you fill it" policy.

  • Identification #: HA Policy 04-032
  • Date: 3/22/2005
  • Type: Memorandums
  • Topics: TRICARE Formulary

TRICARE Pharmacy Benefit Program Formulary Management


The Department ofDefense was directed to establish an effective, efficient, integrated pharmacy benefits program for the Military Health System, to include a Uniform Formulary of pharmaceutical agents.

  • Identification #: HA Policy: 04-032
  • Date: 12/22/2004
  • Type: Memorandums
  • Topics: TRICARE Formulary
<< < 1 > >> 
Showing results 1 - 13 Page 1 of 1

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing: Download a PDF Reader or learn more about PDFs.